Tags
The maker of EpiPens offered patients more help to pay for its costly emergency allergy shots but didn’t budge Thursday on the $608 price. The announcement from Mylan triggered a new round of condemnation from consumer groups and politicians, who accuse the company of price-gouging on a potentially lifesaving treatment. Critics stressed that insurers, employers […]